Hyperaldosteronism: Difference between revisions
No edit summary |
|||
Line 16: | Line 16: | ||
!Category | !Category | ||
!Diseases | !Diseases | ||
! | !Explanation | ||
! | ! | ||
! | ! | ||
Line 62: | Line 62: | ||
| | | | ||
* Pure [[aldosterone]]-producing [[Adrenal carcinoma|adrenocortical carcinomas]] | * Pure [[aldosterone]]-producing [[Adrenal carcinoma|adrenocortical carcinomas]] | ||
| | |Multi factorial, cancer causes, genetic causes | ||
| | | | ||
| | | | ||
Line 68: | Line 68: | ||
| | | | ||
* Unilateral [[adrenal hyperplasia]] | * Unilateral [[adrenal hyperplasia]] | ||
| | |ACTH excess | ||
| | | | ||
| | | | ||
|- | |- | ||
! rowspan=" | ! rowspan="9" |Secondary hyperaldosteronism | ||
|Genetic mutation | |||
|Bartter and Gitelman syndromes | |Bartter and Gitelman syndromes | ||
|Hyperplasia of the juxtaglomerular apparatus (the source of renin in the kidney) | |Hyperplasia of the juxtaglomerular apparatus (the source of renin in the kidney) | ||
| | | | ||
| | | |
Revision as of 13:35, 21 September 2017
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
This page contains general information about Hyperaldosteronism. For more information on specific types, please visit the pages on Primary hyperaldosteronism, and Secondary hyperaldosteronism.
Synonyms and keywords: Aldosteronism
Overview
Classification
Aldosteronism and mineralocorticoid excess may be classified into two types, primary hyperaldosteronism (conn's syndrome) and secondary hyperaldosteronism. The different types of aldosteronism described in the below table:
Primary hyperaldosteronism | Category | Diseases | Explanation | ||
---|---|---|---|---|---|
Adrenal causes |
|
Benign tumor | |||
|
Bilateral hyperplasia of the adrenal gland | ||||
Extra-adrenal causes |
|
Ovaries and kidneys | |||
Familial hyperaldosteronism |
|
Glucocorticoid-remediable aldosteronism [GRA] | |||
|
Familial occurrence of aldosterone-secreting adrenal adenoma or bilateral idiopathic hyperplasia or both | ||||
|
Associated with the germline mutation in the KCNJ5 potassium channel | ||||
Other |
|
Multi factorial, cancer causes, genetic causes | |||
|
ACTH excess | ||||
Secondary hyperaldosteronism | Genetic mutation | Bartter and Gitelman syndromes | Hyperplasia of the juxtaglomerular apparatus (the source of renin in the kidney) | ||
Endocrine causes | Cushing syndrome | ||||
Ectopic ACTH production | |||||
Renovascular | Kidney transplant | ||||
Renin-secreting juxtaglomerular cell tumors | |||||
Scleroderma renal crisis | |||||
Malignant hypertension | |||||
Tumors | Reninoma | ||||
Intravascular hypovolemia | heart failure, hepatic cirrhosis, and nephrotic syndrome |
Pseudohyperaldosteronism causes (low renin):
Pseudohyperaldosteronism causes | Disease | Etiology | Clinical features | Labratory | ||||
---|---|---|---|---|---|---|---|---|
Elevated mineralocorticoid | Renin | Aldosterone | Other | Treatment | ||||
Endogenous causes | 17 alpha-hydroxylase deficiency | Mutations in the CYP17A1 gene |
|
Deoxycorticosterone (DOC) | ↓ | ↓ | Cortisol ↓ | Corticosteroids |
11β-hydroxylase deficiency | Mutations in the CYP11B1 gene |
|
Cortisol ↓ | |||||
Apparent mineralocorticoid excess syndrome (AME) | Genetic or acquired defect of 11-HSD
|
|
Cortisol has mineralocorticoid effects | ↓ | ↓ | Urinary free cortisone ↓↓ | Dexamethasone and/or mineralocorticoid blockers | |
Liddle’s syndrome (Pseudohyperaldosteronism type 1) | Mutation of the epithelial sodium channels (ENaC) gene in the distal renal tubules |
|
No extra mineralocorticoid presents, and mutations in Na channels mimic aldosterone mechanism | ↓ | ↓ | Cortisol ↓ | amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone | |
Cushing’s syndrome | The main pathogenetic mechanism is linked to the excess
of cortisol which saturates 11-HSD2 activity, allowing cortisol to bind MR. A similar picture is also related to over secretion of cortisol by adrenocortical carcinomas. In some cases the disease is associated with secondary hyperaldosteronism due to a direct activation of the renin angiotensin system by glucocorticoids. |
Rapid weight gain, particularly of the trunk and face with limbs sparing (central obesity)
|
Cortisol has mineralocorticoid effects | ↓ |
|
Urinary free cortisol markedly ↑↑ |
| |
Insensitivity to glucocorticoids (Chrousos syndrome) | Mutations in glucocorticoid receptor (GR) gene |
|
Deoxycorticosterone (DOC) | ↓ | ↓ | Cortisol | Dexamethasone | |
Aldosterone-secreting adrenocortical carcinoma | Cortisol has mineralocorticoid effects | ↓ |
|
Urinary free cortisol markedly ↑↑ | ||||
Geller’s syndrome | mutation of MR that alters its specificity and allows progesterone to bind MR | severe hypertension particularly during pregnancy | ↓ | ↓ | ||||
Gordon’s syndrome (Pseudohypoaldosteronism type 2) | Mutations of at least four genes have been identified, including WNK1 and WNK4 |
|
No excess mineralocorticoid; an increased activity of the thiazide-sensitive Na–Cl co-transporter in the distal tubule | ↓ | Normal | Hyperkalemia | thiazide diuretics and/or dietary sodium restriction | |
Exogenous causes | Corticosteroids with mineralocorticoid activity | Fludrocortisone or fluoroprednisolone can mimic the action of aldosterone, |
|
Medications such as Fludrocortisone | ↓ | ↓ | - | Change the treatment |
Licorice ingestion | glycyrrhetinic acid that binds MR and blocks 11-HSD2 at the level of classical target tissues of aldosterone | ↓ | ↓ | Urinary free cortisol Moderate ↑ | ||||
grapefruit | High assumption of naringenin, a component of grapefruit, can also block 11-HSD | |||||||
Contraceptives | Estrogens can retain sodium and water by different mechanisms, causing increased blood pressure values and suppressing the renin aldosterone system. However, contraceptives usually cause hypertension through a secondary hyperaldosteronism due to the stimulation of the synthesis of angiotensinogen | |||||||
Particular causes of hypertension | Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly) | |||||||
FANS | ||||||||
B-Adrenergic agonists | ||||||||
Aging | ||||||||
Low-renin essential hypertension | ||||||||
Autonomic dysfunction | ||||||||
Partial/total nephrectomy or removal of renal tissue |
Differentiating Diagnosis
Hyperaldosteronism should be differentiated from other diseases causing hypertension and hypokalemia for example:
- Renal artery stenosis
- Cushing's syndrome
- Congenital adrenal hyperplasia (CAH)
- Liddle's syndrome
- Diuretic use
- Licorice ingestion
- Renin-secreting tumors
Hypertension and Hypokalemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Plasma renin activity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal or High (Plasma Renin/Aldosterone ratio <10 | Suppressed (Plasma Renin/Aldosterone ratio >20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Renin-secreting tumors *Diuretic use *Renovascular hypertension *Coarctation of aorta *Malignant phase hypertension | Urinary aldosterone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Elevated | Normal | Low | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conn's syndrome (Primary aldosteronism) | Profound K+ depletion | • 17 alpha hydroxylase deficiency • 11 beta hydroxylase deficiency • Liddle's syndrome • Licorice ingestion • Deoxycortisone producing tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add Mineralocrticoid antagonist for 8 weeks | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BP response | No BP response | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency) • Licorice ingestion •Glucocorticoid resistance | Liddle's syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||